HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc.® (the “Company”) (NASDAQ: ACOR) announced today that the underwriters of its February 2008 public offering of common stock have exercised their entire option to purchase an additional 495,000 shares of common stock. The exercise of the option increases the size of the offering to an aggregate of 3,795,000 shares of common stock.
